Co-organized by BioCT, PhRMA and the Bipartisan Bioscience Caucus, please join us for the first in a two part series highlighting Connecticut’s bioscience footprint. During our discussion, we will learn about the scientific breakthroughs participating companies have made in the fight against the COVID pandemic, and dive into the industry’s impact on the overall health and vitality of the state, from both public health and economic perspective.
Industry executives will discuss their respective R&D pipelines and therapeutic discoveries, as well as varied commercial paths to growth (challenges and opportunities) and future business goals.
*PhRMA – Welcome
*BioCT – Introductions: BioCT’s Government Affairs Committee members
*Discussion with Bioscience Caucus
*Discussion with Industry Leaders
John Houston, PhD, President & CEO, Arvinas
Doug Manion, MD, Chairman of the Board & CEO, Kleo Pharmaceuticals
Jit (Abhijit) Banerjee, PhD, Associate VP for Innovation & Entrepreneurship, UConn
Bijan Almassian, PhD, Co-Founder, President & CEO, Carogen Corporation
Hosted by: AdvanceCT
Sponsored by: BIO
A special thank you to BioCT’s Government Affairs Committee for their stewardship of this event.